The role of Bcl-xL and nuclear factor-κB in the effect of taxol on the viability of dendritic cells

다국어 초록 (Multilingual Abstract)

Taxol has been used effectively in cancer therapies. Our previous study demonstrated that taxol induced altered maturation and improved viability of dendritic cells (DCs). However, the effects of taxol on DC viability have not been fully elucidated. In the present study, flow cytometric analyses revealed that taxol treatment significantly increased the number of viable DCs and the expression levels of a representative anti-apoptotic protein Bcl-xL. Furthermore, mobilization of the p65 subunit of nuclear factor-κB (NF-κB) from the cytosol to the nucleus in DCs was observed by confocal microscopy. An inhibition assay using N-p-tosyl-L-phenylalanine chloromethyl ketone confirmed that NF-κB was intimately involved in the effects of taxol on DC viability. In addition, we investigated the mechanisms of taxol enhancement of DC viability. Since taxol is a popular anticancer agent used in clinic, this study may provide a rationale for the use of taxol in DC immunotherapy to treat cancer patients. Taken together, these results confirm that taxol increases DC viability, and this information may provide new insights for new clinical applications of both taxol and DCs.

참고문헌 (Reference)

1 Pirtskhalaishvili G, "Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice" 165 : 1956-1964, 2000

2 Rowinsky EK, "Taxol: a novel investigational antimicrotubule agent" 82 : 1247-1259, 1990

3 Hong-Gu Joo, "Radioprotective effects of an acidic polysaccharide of Panaxginseng on bone marrow cells" 대한수의학회 8 (8): 39-44, 2007

4 Rang HP, "Pharmacology. 5th ed" Kidlington 696-698, 2004

5 Wiseman LR, "Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers" 12 : 305-334, 1998

6 Mullins DW, "Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide" 162 : 6811-6818, 1999

7 Kubo M, "Nakashima H, Kuroki H, Nakamura K, Nakamura M, Katano M. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production" 54 : 468-476, 2005

8 Chu Q, "Lung Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systemic review and practice guideline" 50 : 355-374, 2005

9 Zhong H, "Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth" 13 : 5455-5462, 2007

10 Kim YM, "Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells" 326 : 410-416, 2005

11 Kim MH, "Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells" 115 : 138-143, 2008

12 Joo HG, "Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes" 69 : 555-564, 2001

13 Banchereau J, "Dendritic cells and the control of immunity" 392 : 245-252, 1998

14 Blanco P, "Dendritic cells and cytokines in human inflammatory and autoimmune diseases" 19 : 41-52, 2008

15 Liau LM, "Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment" 11 : 5515-5525, 2005

16 Rescigno M, "Dendritic cell survival and maturation are regulated by different signaling pathways" 188 : 2175-2180, 1998

17 Ouaaz F, "Dendritic cell development and survival require distinct NF-κB subunits" 16 : 257-270, 2002

18 최광성, "Combined Treatment of an Intratumoral Injection of Dendritic Cells and Systemic Chemotherapy (Paclitaxel) for Murine Fibrosarcoma" 연세대학교의과대학 46 (46): 835-842, 2005

19 Nopora A, "Bcl-2 controls dendritic cell longevity in vivo" 169 : 3006-3014, 2002

20 Kriehuber E, "Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death" 106 : 175-183, 2005

21 Opferman JT, "Apoptosis in the development and maintenance of the immune system" 4 : 410-415, 2003

22 Hong-Gu Joo, "Altered maturation of dendritic cells by taxol, an anticancer drug" 대한수의학회 4 (4): 229-234, 2003

23 Hou WS, "A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells" 5 : 583-589, 2004